End-stage heart failure secondary to low-dose hydroxychloroquine treatment.

Figliozzi, Stefano; Rizzo, Stefania; De Gaspari, Monica; Tarantini, Giuseppe

Figliozzi, Stefano; Rizzo, Stefania; De Gaspari, Monica; Tarantini, Giuseppe.

Figliozzi S; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.
Rizzo S; Cardiovascular Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health,University of Padua Medical School Via A. Gabelli, 61 35121 Padua, Italy.
De Gaspari M; Cardiovascular Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health,University of Padua Medical School Via A. Gabelli, 61 35121 Padua, Italy.
Tarantini G; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.

Eur Heart J ; 42(2): 207, 2021 01 07.

Article in English | MEDLINE | ID: covidwho-684328

Subject(s)

COVID-19; Heart Failure; Heart Failure/chemically induced; Heart Failure/drug therapy; Humans; Hydroxychloroquine/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Limits: Humans Language: English Journal: Eur Heart J Year: 2021 Document Type: Article Affiliation country: Eurheartj

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google